JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Thursday, April 3, 2025

COVID-19

Covid-19 Cases in Trinidad and Tobago

Updated: 4/3/2025, 9:28:30 AMTotal Cases: 191496Active Cases: 28Critical Cases: 0Total Deaths: 4390Recovered: 187078Total Tested: 913289
« 1 ... 23 24 25 26 27 28 29 ... 130 »

6 COVID deaths, 963 new cases

by

Fri Feb 11 2022
Registered nurse NIKITA MEDINA, 39, of Siparia, along with administrative clerks KEVON MOSES, 39, of Claxton Bay, and RICHARD RODRIGUEZ, 30, of Palo Seco, are charged with conspiracy to misbehave in public office. (Images courtesy TTPS)

Registered nurse NIKITA MEDINA, 39, of Siparia, along with administrative clerks KEVON MOSES, 39, of Claxton Bay, and RICHARD RODRIGUEZ, 30, of Palo Seco, are charged with conspiracy to misbehave in public office. (Images courtesy TTPS)

Bail for suspects in false COVID-19 immunization cards scheme

by

Fri Feb 11 2022

26 new COVID infections, 12 hospitalised in Tobago

by

Fri Feb 11 2022
FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

AstraZeneca sees $4B in COVID vaccine sales as revenue soars

by

Thu Feb 10 2022

6 more COVID deaths, 738 new cases

by

Thu Feb 10 2022
Ray Hoffman, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, a medical assistant at a University of Washington Medicine clinic in Seattle. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Ray Hoffman, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, a medical assistant at a University of Washington Medicine clinic in Seattle. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Most vulnerable still in jeopardy as COVID precautions ease

by

Thu Feb 10 2022

52 new COVID cases in Tobago, no new deaths

by

Thu Feb 10 2022
Minister of Social Development and Family Services, Senator Donna Cox.  (Image courtesy Ministry of Social Development and Family Services)

Minister of Social Development and Family Services, Senator Donna Cox. (Image courtesy Ministry of Social Development and Family Services)

Soc Dev Ministry committed to building resiliency for post pandemic recovery – Minister

by

Thu Feb 10 2022
An illustration of a person pulling a piece of cloth off a table to reveal a large COVID virus. [Muaz Kory/Al Jazeera]

An illustration of a person pulling a piece of cloth off a table to reveal a large COVID virus. [Muaz Kory/Al Jazeera]

NeoCov: What is this virus and should we be worried?

by

Thu Feb 10 2022
FILE - In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

FILE - In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

CARPHA: Don’t use adult Pfizer COVID vaccine on kids 5-11 years

by

Thu Feb 10 2022

Pandemic continues to challenge region’s health care workers – PAHO

by

Thu Feb 10 2022
People wearing protective masks to help curb the spread of the coronavirus wait for a traffic light at an intersection in Tokyo [File: Eugene Hoshiko/AP Photo]

People wearing protective masks to help curb the spread of the coronavirus wait for a traffic light at an intersection in Tokyo [File: Eugene Hoshiko/AP Photo]

Catching COVID more than once: What we know about reinfections

by

Wed Feb 09 2022
« 1 ... 23 24 25 26 27 28 29 ... 130 »
« 1 ... 23 24 25 26 27 28 29 ... 131 »
An illustration of a scientist examining a giant COVID-19 cell through a magnifying glass. [Muaz Kory/Al Jazeera]

An illustration of a scientist examining a giant COVID-19 cell through a magnifying glass. [Muaz Kory/Al Jazeera]

What will the next generation of COVID vaccines look like?

● The next gen­er­a­tion of shots will of­fer a broad­er and more ro­bust im­mune re­sponse. Plus, why it is im­por­tant to mon­i­tor known HIV vari­ants ●

by

Mon Feb 14 2022
FILE - A woman receives a COVID-19 vaccine injection by a pharmacist at a clinic in Lawrence, Mass., on Wednesday, Dec. 29, 2021. One of the first studies to look at the performance of COVID-19 booster shots during the recent omicron wave of illnesses found a surprising decline in effectiveness after only four months. The findings are based on data from hospitals and urgent care centers in 10 states. (AP Photo/Charles Krupa, File)

FILE - A woman receives a COVID-19 vaccine injection by a pharmacist at a clinic in Lawrence, Mass., on Wednesday, Dec. 29, 2021. One of the first studies to look at the performance of COVID-19 booster shots during the recent omicron wave of illnesses found a surprising decline in effectiveness after only four months. The findings are based on data from hospitals and urgent care centers in 10 states. (AP Photo/Charles Krupa, File)

Study: COVID booster effectiveness wanes but remains strong

NEW YORK (AP) — An ear­ly look at the per­for­mance of COVID-19 boost­er shots dur­ing the re­cent omi­cron wave in the U.S. hint­ed at a de­cline in ef­fec­tive­ness, though the shots still of­fered strong pro­tec­tion against se­vere ill­ness.

by

Sat Feb 12 2022

6 COVID deaths, 963 new cases

The Min­istry of Health has record­ed 6 ad­di­tion­al COVID re­lat­ed death. This brings the to­tal num­ber of deaths to 3,507. There are cur­rent­ly 309 pa­tients in the hos­pi­tal. The min­istry has al­so record­ed 963 new COVID cas­es in the last 24 hours, bring­ing the to­tal num­ber of ac­tive cas­es to 21,267.

by

Fri Feb 11 2022
Registered nurse NIKITA MEDINA, 39, of Siparia, along with administrative clerks KEVON MOSES, 39, of Claxton Bay, and RICHARD RODRIGUEZ, 30, of Palo Seco, are charged with conspiracy to misbehave in public office. (Images courtesy TTPS)

Registered nurse NIKITA MEDINA, 39, of Siparia, along with administrative clerks KEVON MOSES, 39, of Claxton Bay, and RICHARD RODRIGUEZ, 30, of Palo Seco, are charged with conspiracy to misbehave in public office. (Images courtesy TTPS)

Bail for suspects in false COVID-19 immunization cards scheme

Bail was grant­ed to three per­sons who were caught dur­ing a sting op­er­a­tion crack­ing down on the con­spir­a­cy to il­le­gal­ly is­sue false COVID-19 im­mu­niza­tion cards at the Fyz­abad Health Fa­cil­i­ty, af­ter they ap­peared be­fore a Jus­tice of the Peace, on Thurs­day.

by

Fri Feb 11 2022

26 new COVID infections, 12 hospitalised in Tobago

There are 26 new pos­i­tive COVID-19 cas­es in To­ba­go over the past 24 hours, but for­tu­nate­ly, no new deaths.

by

Fri Feb 11 2022
FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

AstraZeneca sees $4B in COVID vaccine sales as revenue soars

LON­DON (AP) — As­traZeneca record­ed a big jump in rev­enue on Thurs­day as it be­gins to take a prof­it from its coro­n­avirus vac­cine for the first time.

by

Thu Feb 10 2022

6 more COVID deaths, 738 new cases

The Min­istry of Health has record­ed 6 ad­di­tion­al COVID re­lat­ed death. This brings the to­tal num­ber of deaths to 3,501. There are cur­rent­ly 439 pa­tients in the hos­pi­tal. The min­istry has al­so record­ed 738 new COVID cas­es in the last 24 hours, bring­ing the to­tal num­ber of ac­tive cas­es to 21,045.

by

Thu Feb 10 2022
Ray Hoffman, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, a medical assistant at a University of Washington Medicine clinic in Seattle. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Ray Hoffman, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, a medical assistant at a University of Washington Medicine clinic in Seattle. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Most vulnerable still in jeopardy as COVID precautions ease

(AP) — Two years in­to the pan­dem­ic Jack­ie Hansen still left home on­ly for doc­tor vis­its, her im­mune sys­tem so wrecked by can­cer and lu­pus that COVID-19 vac­ci­na­tions couldn’t take hold.

by

Thu Feb 10 2022

52 new COVID cases in Tobago, no new deaths

No new deaths from COVID-19 have been record­ed in To­ba­go over the past 24 hours, ac­cord­ing to the up­date for Wednes­day 9th Feb­ru­ary 2022, re­leased by the Di­vi­sion of Health, Well­ness and So­cial Pro­tec­tion, in the To­ba­go House of As­sem­bly (THA).

by

Thu Feb 10 2022
Minister of Social Development and Family Services, Senator Donna Cox.  (Image courtesy Ministry of Social Development and Family Services)

Minister of Social Development and Family Services, Senator Donna Cox. (Image courtesy Ministry of Social Development and Family Services)

Soc Dev Ministry committed to building resiliency for post pandemic recovery – Minister

“The Gov­ern­ment of Trinidad and To­ba­go con­tin­ues to de­liv­er a range of so­cial sup­port mea­sures to cush­ion the reper­cus­sions of the pan­dem­ic…”

by

Thu Feb 10 2022
An illustration of a person pulling a piece of cloth off a table to reveal a large COVID virus. [Muaz Kory/Al Jazeera]

An illustration of a person pulling a piece of cloth off a table to reveal a large COVID virus. [Muaz Kory/Al Jazeera]

NeoCov: What is this virus and should we be worried?

● It is im­por­tant to re­search this coro­n­avirus that can cross from bats to hu­mans, but we must not pan­ic ●

by

Thu Feb 10 2022
FILE - In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

FILE - In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

CARPHA: Don’t use adult Pfizer COVID vaccine on kids 5-11 years

The Caribbean Pub­lic Health Agency (CARPHA) is cau­tion­ing re­gion­al Min­istries of Health against us­ing adult for­mu­la­tions of the Pfiz­er-BioN­Tech COVID-19 vac­cine for the vac­ci­na­tion of chil­dren aged 5 to 11 years of age, even as it en­cour­ages them to con­tin­ue rolling out their na­tion­al vac­ci­na­tion cam­paigns.

by

Thu Feb 10 2022
« 1 ... 23 24 25 26 27 28 29 ... 131 »
« 1 ... 23 24 25 26 27 28 29 ... 130 »
FILE - A woman receives a COVID-19 vaccine injection by a pharmacist at a clinic in Lawrence, Mass., on Wednesday, Dec. 29, 2021. One of the first studies to look at the performance of COVID-19 booster shots during the recent omicron wave of illnesses found a surprising decline in effectiveness after only four months. The findings are based on data from hospitals and urgent care centers in 10 states. (AP Photo/Charles Krupa, File)

FILE - A woman receives a COVID-19 vaccine injection by a pharmacist at a clinic in Lawrence, Mass., on Wednesday, Dec. 29, 2021. One of the first studies to look at the performance of COVID-19 booster shots during the recent omicron wave of illnesses found a surprising decline in effectiveness after only four months. The findings are based on data from hospitals and urgent care centers in 10 states. (AP Photo/Charles Krupa, File)

Study: COVID booster effectiveness wanes but remains strong

by

Sat Feb 12 2022

6 COVID deaths, 963 new cases

by

Fri Feb 11 2022
Registered nurse NIKITA MEDINA, 39, of Siparia, along with administrative clerks KEVON MOSES, 39, of Claxton Bay, and RICHARD RODRIGUEZ, 30, of Palo Seco, are charged with conspiracy to misbehave in public office. (Images courtesy TTPS)

Registered nurse NIKITA MEDINA, 39, of Siparia, along with administrative clerks KEVON MOSES, 39, of Claxton Bay, and RICHARD RODRIGUEZ, 30, of Palo Seco, are charged with conspiracy to misbehave in public office. (Images courtesy TTPS)

Bail for suspects in false COVID-19 immunization cards scheme

by

Fri Feb 11 2022

26 new COVID infections, 12 hospitalised in Tobago

by

Fri Feb 11 2022
FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

AstraZeneca sees $4B in COVID vaccine sales as revenue soars

by

Thu Feb 10 2022

6 more COVID deaths, 738 new cases

by

Thu Feb 10 2022
Ray Hoffman, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, a medical assistant at a University of Washington Medicine clinic in Seattle. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Ray Hoffman, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, a medical assistant at a University of Washington Medicine clinic in Seattle. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Most vulnerable still in jeopardy as COVID precautions ease

by

Thu Feb 10 2022

52 new COVID cases in Tobago, no new deaths

by

Thu Feb 10 2022
Minister of Social Development and Family Services, Senator Donna Cox.  (Image courtesy Ministry of Social Development and Family Services)

Minister of Social Development and Family Services, Senator Donna Cox. (Image courtesy Ministry of Social Development and Family Services)

Soc Dev Ministry committed to building resiliency for post pandemic recovery – Minister

by

Thu Feb 10 2022
An illustration of a person pulling a piece of cloth off a table to reveal a large COVID virus. [Muaz Kory/Al Jazeera]

An illustration of a person pulling a piece of cloth off a table to reveal a large COVID virus. [Muaz Kory/Al Jazeera]

NeoCov: What is this virus and should we be worried?

by

Thu Feb 10 2022
FILE - In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

FILE - In this photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

CARPHA: Don’t use adult Pfizer COVID vaccine on kids 5-11 years

by

Thu Feb 10 2022

Pandemic continues to challenge region’s health care workers – PAHO

by

Thu Feb 10 2022
« 1 ... 23 24 25 26 27 28 29 ... 130 »